Increased Oxidative Stress in the Proximal Stomach of Patients with Barrett’s Esophagus and Adenocarcinoma of the Esophagus and Esophagogastric Junction  by Kauppi, Juha et al.
www.transonc.com
Trans la t iona l Onco logy Volume 9 Number 4 August 2016 pp. 336–339 336Increased Oxidative Stress in the




Esophagogastric Junction1Juha Kauppi*, Jari Räsänen*, Eero Sihvo*,
Urpo Nieminen†, Perttu Arkkila†,
Markku Ahotupa‡ and Jarmo Salo*
*Helsinki University, Helsinki University Hospital, Heart and
Lung Center, Department of General Thoracic and Esophageal
Surgery, 00290,Helsinki, Finland; †Helsinki University, Helsinki
University Hospital, Department of Gastroenterology, 00290,
Helsinki, Finland; ‡Turku University, Department of
Biosciences, 20520, Turku, FinlandAbstract
OBJECTIVES: Oxidative stress (OS) is an essential element in the pathogenesis of Barrett’s esophagus (BE) and its
transformation to adenocarcinoma (EAC). The state of OS in the proximal stomach of patients with BE and EAC is
unknown. Isoprostanes are a specificmarker of OS not previously used to determineOS fromBE/EAC tissue samples.
PATIENTS AND METHODS: OS was measured in 42 patients with BE (n = 9), EAC (n = 9), or both (n = 24) and 15
control patients. A STAT-8-Isoprostane EIA Kit served to identify 8-Isoprostanes (8-IP), and a Glutathione Assay Kit was
used tomeasure glutathione reduced form (GSH) and glutathione oxidized form. AnOxiSelect Oxidative DNADamage
ELISA Kit (8-OHdG) served to measure 8-OH-deoxyguanosine. RESULTS: The 8-IP (P = .039) and 8-OHdG (P = .008)
levels were higher, and the GSH level lower (P= .031), in the proximal stomach of the study group than in that of the
controls. Helicobacter pylori infection was present in 8% of the study patients. CONCLUSIONS: In the proximal
stomach of BE and EAC patients, OSwas elevated and antioxidative capacity was reduced. This finding suggests that
the gastroesophageal reflux causing BE also induces oxidative stress in the proximal stomach and may contribute to
the development of cancer in the proximal stomach and gastric cardia.
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Adenocarcinoma of the esophagus and esophagogastric junction (EAC) is a
disease with a poor prognosis and rising incidence. Its most important risk
factors are gastroesophageal reflux disease (GERD) and Barrett’s esophagus
(BE) [1]. Long-lasting GERD causes chronic inflammation and greater
accumulation of intracellular reactive oxygen species (ROS), leading to a
state of oxidative stress (OS) [2–5]. ROS modify DNA bases, causing the
production of DNA adducts that can serve as markers of DNA damage.
These adducts can initiate mutagenic and carcinogenic processes by
producing mispaired DNA sequences [2,6–10]. ROS levels are known to
be higher in tissues with BE andEAC [10–15]. Themost commonmarker
of oxidative DNA damage is 8-OH-deoxyguanosine (8-OHdG), which
plays an essential role in the induction of spontaneous mutations [16]. Its
presence inBE, BEdysplasia, andEAC tissues is significantly higher than in
the normal squamous esophageal epithelium [3].
The glutathione redox system and superoxide dismutase
(SOD) function as a defense mechanism against OS [17,18]. Inprevious studies, the GSH content and SOD contents were markedly
lower in Barrett’s epithelium than in normal esophageal mucosa
[12,15,19,20].
8-Iso-PGF2 (8IP), a prostaglandin-like compound produced via
cyclooxygenase-independent enzymes, is considered the most sensitive
and reliable marker of lipid peroxidation and an indicator of oxidative
status in vivo [21,22]. Its circulating plasma levels have been associated
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malignant processes. To our knowledge, however, 8-Iso-PGF2 (8IP) has
not been measured in BE or EAC tissue samples.
Inflammation of the gastric cardia is associated not only with Helico-
bacter pylori infection (HPI) due to pangastritis but also with erosive
esophagitis and GERD in patients without HPI [26]. The association
between cardiac inflammation and EAC is unclear, and most cases are
associated with BE [27–29]. Because inflammation and OS are strongly
linked, in this study, we evaluated whetherOS is present and estimated the
antioxidant capacity of the proximal stomach of patientswithBE andEAC.
Materials and Methods
Patients
Our study included 57 patients (Table 1). Nine samples came from
patients with only esophageal intestinal metaplasia (histologically
observable goblet cells in the tubular esophagus), 9 from patients with
EAC, and 24 with both. Eleven patients in EAC group had undergone
neoadjuvant chemotherapy. The control group contained 15 patients
with no reflux symptoms and a healthy esophagus in the endoscopic
examination. The biopsies from the control patients also revealed healthy
gastric mucosa. We evaluated the study patients’ records for a history of
HPI. Patients in the control group were significantly younger (P = .015,
independent-samples median test). The ethics committee of the Helsinki
University Hospital approved the study protocol.
Sample Collection
We acquired samples from follow-ups with Barrett’s patients and the
pretreatment endoscopies of esophageal adenocarcinoma patients, or
from resected specimens during surgery (11 of the EAC samples). In
endoscopy, we sampled the most obvious area of pathology, including
both the tumor and metaplastic mucosa, if present. Proximal gastric
mucosal samples were taken 5 cm below the top of the proximal gastric
folds. In the control patients, squamous epithelium samples were taken
5 cm above the gastroesophageal junction. All samples were immediately
frozen and stored at −70°C and later sent for analysis.
Methods
Before the biochemical analyses, we homogenized the tissue specimens
in ice-cold 0.1 M Tris buffer with 1 mM EDTA and 10 mM
indomethacin at pH 7.4. A STAT-8-Isoprostane EIA Kit (Cayman
Chemical, Ann Arbor, MI) served to identify 8-Isoprostanes, and a
Glutathione Assay Kit by Cayman Chemical was used to measure
reduced glutathione (GSH) and oxidized glutathione forms (GSSG). An
OxiSelect Oxidative DNADamage ELISA Kit (8-OHdG) (Cell Biolabs,
Inc., San Diego, CA) served to measure 8-OH-deoxyguanosine.
Statistical Methods
All statistical data are expressed as median (range). Mann-Whitney
U test served to compare medians between patient groups. SignificanceTable 1. Patient Groups
Group n Age (Year), Median (Range)
Control 15 46 (20-75)
BE 9 58 (33-81)
EAC 9 69 (58-78)
BE and EAC 24 63 (40-80)
Total 57
Abbreviations: BE, Barrett´s esophagus; EAC, Esophageal adenocarcinoma.was set to P b .05, and all P values were based on two-sided tests. SPSS
software (SPSS Inc., Chicago, IL) served to calculate the statistics.
Results
HPIwas present in 3/38 (8%) of the study patients. The 8-IP (P = .039)
and 8-OHdG (P = .008) content (Figure 1) was higher, and the GSH
content (Figure 2) lower (P = .031), in the proximal stomach of study
group patients than in that of the controls. In the BE samples, the 8-IP
(P = .007) and 8-OHdG (P = .022) content (Figure 1) was higher and
the GSH content (P = .042) (Figure 2) lower than in the control
patients’ samples taken above theGE junction. In the EAC samples, the
8-IP (P = .044) and 8-OHdG (P = .008) content (Figure 1) was higher
and the GSH content (P = .001) (Figure 2) lower than in the control
patients’ samples taken above the GE junction. The study and control
patients also showed no difference in GSSG levels (Figure 1).
Discussion
Our study shows that active lipid peroxidation, as detected with
elevated 8IP, was higher in the mucosa of the proximal stomach of BE
and EAC patients than in that of healthy controls. Moreover, levels of
8-OHdG were elevated, indicating DNA damaged by ROS. GSH
levels were also lower, suggesting either growing consumption or
defective antioxidant capacity or both.
The etiology of adenocarcinoma in gastric cardia is considered more
heterogenic than that of distal esophagus with intestinal metaplasia.
Yamada et al. [28] evaluated 121patientswith cardiac EACand found that
55% of all of the patients had histologic gastritis in the proximal stomach
and 38% of patients with BE had gastritis. Etiology appeared to be
multifactorial, with one third of cardiac EACs occurringwithout BE, likely
from the proximal gastric mucosa. Of all of the patients, 85% also had
esophagitis, which is a known risk factor even without BE [29].Wijetunge
et al. [30] reviewed gastric biopsies from 234 patients with either distal
esophageal high-grade dysplasia or EAC, or cardiac EAC in comparison to
controls with normal esophageal and gastric mucosa. Gastric biopsies were
normal in 85.6% of study group patients, and the rest (14.4%) had either
carditis, HPI, or gastric intestinal metaplasia. They found no differences
related to pathological gastric mucosal findings between distal esophageal
or cardiac EAC and concluded that most cardiac EACs have their origins
in BE mucosa. This suggests that gastroesophageal reflux has a role in the
inflammation andOS of the proximal stomachmucosa. Because all of our
patients also had BE, most must also have GERD.Moreover, because the
patients in our study group also had a low incidence of HPI, GERD being
related to OS in the proximal stomach is a more likely explanation.
Duodenogastric reflux (DGR) is known to cause gastritis in patients with
partial gastrectomy [31]. It may be speculated that DGR is causing
inflammation not only in the esophagus but also in gastric mucosa and
thereby causing oxidative damage in cardiac region. This hypothesis is
supported by results from Dixon et al. [32] pointing out association with
DGR, inflammation, and intestinal metaplasia at cardia unrelated to HPI.
Similar association was also suggested by Voutilainen et al. [26].
In a previous study by our group [12], DNA adducts were more
numerous in the BE and EAC samples than in those of the control
patients, and most numerous in the BE samples. GSH and DNA
adduct levels also showed a negative correlation; this study shows
the same results. In a study by Peters et al. [19], GSH levels were
lower in BE and the gastric mucosa than in normal esophageal
squamous epithelium or the duodenal mucosa, which is in line with
our result. Low GSH levels in BE have shown an association with a
risk for EAC, which also supports our results [33]. Another study
Figure 1. Comparisons of 8-IP and 8-OHdG levels between study and control groups. Mann-Whitney U test.
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with GERD were lower than those of control patients in the
proximal esophagus both before and after fundoplication, suggest-
ing a primary deficiency in antioxidant capacity. This deficiency
could also explain lower GSH levels in the proximal cardiac mucosa
of our patients.Figure 2. Comparisons of GSH and GSSG levels betweOur study shows that proximal gastric mucosa adjacent to metaplastic
esophagus reacts to OS and links reflux of duodenal and gastric content in
the pathogenesis of cardiac and distal EAC.Our study is limited by its small
number of patients, and the control patients were younger than average.
However, the data were collected prospectively, and this is the first report to
use isoprostanes analyzed from tissue samples from BE and EAC patients.en study and control groups. Mann-Whitney U test.
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